Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

被引:32
作者
Han, Man-Hoon [1 ]
Lee, Jee Hyun [2 ]
Kim, Gyeonghwa [2 ]
Lee, Eunhye [2 ]
Lee, Yu Rim [3 ]
Jang, Se Young [3 ]
Lee, Hye Won [4 ]
Chun, Jae Min [5 ]
Han, Young Seok [5 ]
Yoon, Jun Sik [6 ]
Kang, Min Kyu [7 ]
Lee, Won Kee [8 ,9 ]
Kweon, Young Oh [3 ]
Tak, Won Young [3 ]
Park, Soo Young [3 ]
Park, Jung Gil [7 ]
Hur, Keun [2 ]
机构
[1] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Pathol, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Daegu 41944, South Korea
[3] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu 41944, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Sch Med, Dept Pathol, Daegu 42601, South Korea
[5] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Surg, Daegu 41944, South Korea
[6] Inje Univ, Busan Paik Hosp, Dept Internal Med, Coll Med, Busan 74392, South Korea
[7] Yeungnam Univ, Coll Med, Dept Internal Med, Daegu 42415, South Korea
[8] Kyungpook Natl Univ, Med Res Collaborat Ctr KNUH, Daegu 42415, South Korea
[9] Kyungpook Natl Univ, Sch Med, Daegu 42415, South Korea
关键词
noncoding RNA; biomarker; lncRNA GAS5; nonalcoholic fatty liver disease; liver fibrosis; CANCER; HOTAIR; LINCRNA-P21; MORTALITY; MECHANISM; DIAGNOSIS; BIOMARKER; FEATURES; CELLS;
D O I
10.3390/genes11050545
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Advanced liver fibrosis is the most important prognostic factor in nonalcoholic fatty liver disease (NAFLD). The long noncoding RNA (lncRNA), growth arrest-specific transcript 5 (GAS5), is associated with the inhibition of liver fibrogenesis, and its levels are decreased in cirrhotic liver. Methods: We analyzed 51 patients with NAFLD, the diagnosis of which was confirmed by liver biopsy. Expression of GAS5 in both the liver and plasma of the patients was analyzed using a quantitative real-time polymerase chain reaction according to the fibrosis stage. Results: Plasma GAS5 expression was significantly higher in patients with advanced fibrosis than in those without. As the fibrosis progressed, GAS5 expression in plasma increased, with the exception of that in cirrhotic livers. Plasma levels of GAS5 were lower in patients with cirrhosis than in those with advanced fibrosis. Conclusion: Elevated circulating levels of the lncRNA GAS5 are associated with the progression of liver fibrosis prior to the development of cirrhosis.
引用
收藏
页数:10
相关论文
共 42 条
  • [1] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    Angulo, Paul
    Kleiner, David E.
    Dam-Larsen, Sanne
    Adams, Leon A.
    Bjornsson, Einar S.
    Charatcharoenwitthaya, Phunchai
    Mills, Peter R.
    Keach, Jill C.
    Lafferty, Heather D.
    Stahler, Alisha
    Haflidadottir, Svanhildur
    Bendtsen, Flemming
    [J]. GASTROENTEROLOGY, 2015, 149 (02) : 389 - +
  • [2] [Anonymous], **DATA OBJECT**, DOI DOI 10.5255/UKDA-SN-7480-1
  • [3] The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
    Ascha, Mustafa S.
    Hanouneh, Ibrahim A.
    Lopez, Rocio
    Tamimi, Tarek Abu-Rajab
    Feldstein, Ariel F.
    Zein, Nizar N.
    [J]. HEPATOLOGY, 2010, 51 (06) : 1972 - 1978
  • [4] p53-dependent Induction of PVT1 and miR-1204
    Barsotti, Anthony M.
    Beckerman, Rachel
    Laptenko, Oleg
    Huppi, Konrad
    Caplen, Natasha J.
    Prives, Carol
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2509 - 2519
  • [5] Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus
    Carter, Gay
    Miladinovic, Branko
    Patel, Achintya A.
    Deland, Lauren
    Mastorides, Stephen
    Patel, Niketa A.
    [J]. BBA CLINICAL, 2015, 4 : 102 - 107
  • [6] The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2012, 55 (06) : 2005 - 2023
  • [7] Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9-Mediated RXRA Signaling Pathway
    Cui, Ming
    Xiao, Zelin
    Wang, Yue
    Zheng, Minying
    Song, Tianqiang
    Cai, Xiaoli
    Sun, Baodi
    Ye, Lihong
    Zhang, Xiaodong
    [J]. CANCER RESEARCH, 2015, 75 (05) : 846 - 857
  • [8] lncRNA GAS5 restrains CCl4-induced hepatic fibrosis by targeting miR-23a through the PTEN/PI3K/Akt signaling pathway
    Dong, Zhiheng
    Li, Sha
    Wang, Xiaohui
    Si, Lengge
    Ma, Ruilian
    Bao, Lidao
    Bo, Agula
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 316 (04): : G539 - G550
  • [9] Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
    Ekstedt, Mattias
    Hagstrom, Hannes
    Nasr, Patrik
    Fredrikson, Mats
    Stal, Per
    Kechagias, Stergios
    Hultcrantz, Rolf
    [J]. HEPATOLOGY, 2015, 61 (05) : 1547 - 1554
  • [10] Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
    Fayda, Merdan
    Isin, Mustafa
    Tambas, Makbule
    Guveli, Murat
    Meral, Rasim
    Altun, Musa
    Sahin, Dilek
    Ozkan, Gozde
    Sanli, Yasemin
    Isin, Husniye
    Ozgur, Emre
    Gezer, Ugur
    [J]. TUMOR BIOLOGY, 2016, 37 (03) : 3969 - 3978